Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Titre (en) » - entrée « experience »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
expensive < experience < experienced  Facettes :

List of bibliographic references indexed by experience

Number of relevant bibliographic references: 86.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000055 (2020) Pan Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine]Tocilizumab treatment in COVID-19: A single center experience.
000061 (2020) Ver Nica Cantarín-Extremera [Espagne] ; María Jiménez-Legido [Espagne] ; Anna Duat-Rodríguez [Espagne] ; Marta García-Fernández [Espagne] ; Nelmar Valentina Ortiz-Cabrera [Espagne] ; María Luz Ruiz-Falc Rojas [Espagne] ; Luis González-Gutiérrez-Solana [Espagne]Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients.
000083 (2020) Wen Zhang [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Fengchun Zhang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Taisheng Li [République populaire de Chine] ; Zhengyin Liu [République populaire de Chine] ; Jinglan Wang [République populaire de Chine] ; Yan Qin [République populaire de Chine] ; Xuan Zhang [République populaire de Chine] ; Xiaowei Yan [République populaire de Chine] ; Xiaofeng Zeng [République populaire de Chine] ; Shuyang Zhang [République populaire de Chine]The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China
000205 (2020) Karin Luttropp [Suède] ; Johan Dalén [Suède] ; Axel Svedbom [Suède] ; Mary Dozier [États-Unis] ; Christopher M. Black [États-Unis] ; Amy Puenpatom [États-Unis]Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review
000292 (2020) Fujun Peng [République populaire de Chine] ; Lei Tu [République populaire de Chine] ; Yongshi Yang [République populaire de Chine] ; Peng Hu [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Qinyong Hu [République populaire de Chine] ; Feng Cao [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Christopher Chang [États-Unis]Management and Treatment of COVID-19: The Chinese Experience
000357 (2020) Zaiwei Song [République populaire de Chine] ; Yang Hu [République populaire de Chine] ; Siqian Zheng [République populaire de Chine] ; Li Yang [République populaire de Chine] ; Rongsheng Zhao [République populaire de Chine]Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience
000368 (2020) Rosanna Dammacco [Italie] ; Giovanni Alessio [Italie] ; Ermete Giancipoli [Italie] ; Patrizia Leone [Italie] ; Anna Cirulli [Italie] ; Leonardo Resta [Italie] ; Angelo Vacca [Italie] ; Franco Dammacco [Italie]Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements
000387 (2020) Jeffrey P. Jacobs [États-Unis] ; Alfred H. Stammers [États-Unis] ; James St Louis [États-Unis] ; J W Awori Hayanga [États-Unis] ; Michael S. Firstenberg [États-Unis] ; Linda B. Mongero [États-Unis] ; Eric A. Tesdahl [États-Unis] ; Keshava Rajagopal [États-Unis] ; Faisal H. Cheema [États-Unis] ; Tom Coley [États-Unis] ; Vinay Badhwar [États-Unis] ; Anthony K. Sestokas [États-Unis] ; Marvin J. Slepian [États-Unis]Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients.
000426 (2020) P. Toby Coates [Australie] ; Germaine Wong [Australie] ; Tilman Drueke [France] ; Brad Rovin [États-Unis] ; Pierre Ronco [France]Early experience with COVID-19 in kidney transplantation
000434 (2020) Rahime Koç [Turquie] ; Hafize Emine Sönmez [Turquie] ; Mustafa Çakan [Turquie] ; Erife Gül Karada [Turquie] ; Ay E Tanatar [Turquie] ; Figen Çakmak [Turquie] ; Nuray Aktay Ayaz [Turquie]Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years' experience of a tertiary pediatric rheumatology center.
000450 (2020) Marta Garrido-Jare O [Espagne] ; Antonio Sahuquillo-Torralba [Espagne] ; Rabab Chouman-Arcas [Espagne] ; Iván Castro-Hernández [Espagne] ; José Miguel Molina-Moreno [Espagne] ; Margarita Llavador-Ros [Espagne] ; María Dolores G Mez-Ruiz [Espagne] ; José Luis L Pez-Hontangas [Espagne] ; Rafael Botella-Estrada [Espagne] ; Miguel Salavert-Lleti [Espagne] ; Javier Pemán-García [Espagne]Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital
000451 (2020) Yue Zhang ; Qianhao Xu ; Zhuoyan Sun ; Lei ZhouCurrent targeted therapeutics against COVID-19: based on first-line experience in china
000575 (2020) Avram Mack ; Hannah-Lise SchofieldApplying (or not?) CAR-T Neurotoxicity Experience to COVID19 Delirium and Agitation
000579 (2020) Levent Kiliç [Turquie] ; Ömer Karada [Turquie] ; Abdulsamet Erden [Turquie] ; Alper Sari [Turquie] ; Berkan Arma An [Turquie] ; Gözde Kübra Yardimci [Turquie] ; Esra Firat [Turquie] ; Umut Kalyoncu [Turquie] ; Ule Apra B Lgen [Turquie] ; Sedat K Raz [Turquie] ; Hsan Ertenl [Turquie] ; Ali Akdo An [Turquie]Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
000693 (2019) Marta Madej [Pologne] ; Patryk Woytala [Pologne] ; Marek Frankowski [Pologne] ; Łukasz Lubi Ski [Pologne] ; Renata Sokolik [Pologne] ; Agata Sebastian [Pologne] ; Beata Maci Ek-Chyra [Pologne] ; Piotr Wiland [Pologne]Tofacitinib in the treatment of active rheumatoid arthritis – single-centre experience
000701 (2019) Selcan Demir [Turquie] ; Hafize Emine Sönmez [Turquie] ; Elif Arslano Lu-Ayd N [Turquie] ; Seza Özen [Turquie] ; Yelda Bilginer [Turquie]Tocilizumab treatment in juvenile idiopathic arthritis patients: A single center experience.
000722 (2019) Filiz Yucebay [États-Unis] ; Christina Matthews [États-Unis] ; Marcin Puto [États-Unis] ; Junan Li [États-Unis] ; Basem William [États-Unis] ; Samantha M. Jaglowski [États-Unis] ; Sam L. Penza [États-Unis] ; Sumithira Vasu [États-Unis] ; Don M. Benson [États-Unis] ; Leslie A. Andritsos [États-Unis] ; Steven M. Devine [États-Unis] ; Yvonne A. Efebera [États-Unis] ; Julianna V F. Roddy [États-Unis]Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.
000810 (2019) Erdal Sa [Turquie] ; Berna Uzuno Lu [Turquie] ; Fatma Bal [Turquie] ; Hafize Emine Sönmez [Turquie] ; Selcan Demir [Turquie] ; Yelda Bilginer [Turquie] ; Seza Özen [Turquie]Systemic onset juvenile idiopathic arthritis: a single center experience.
000950 (2019) Kenan Barut [Turquie] ; Amra Adrovic [Turquie] ; Sezgin Sahin [Turquie] ; Gurkan Tarcin [Turquie] ; Gulberk Tahaoglu [Turquie] ; Oya Koker [Turquie] ; Mehmet Yildiz [Turquie] ; Ozgur Kasapcopur [Turquie]Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
000958 (2019) K. Brazdilova ; T. Koller ; Z. Killinger ; J. PayerPrevalence and risk factors for drug-induced liver injury among patients with rheumatic diseases treated with biological therapy: a single-center experience.
000987 (2019) Denis Choquette [Canada] ; Louis Bessette [Canada] ; Evo Alemao [États-Unis] ; Boulos Haraoui [Canada] ; Roelien Postema [Royaume-Uni] ; Jean-Pierre Raynauld [Canada] ; Louis Coupal [Canada]Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "experience" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "experience" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    experience
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021